Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Case Reports
Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report
Vol. 89 No. 6_Suppl (2004): June, 2004 : Case Reports
Published
2004-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
Article Usage
Online Views
293
PDF Downloads
71
Statistics from Altmetric.com
No Data
How to Cite
1.
A Mele, G Sparaventi, B Guiducci, G Nicolini, F d’Adamo, G Leopardi, C Delfini, P Piccaluga, G Visani. Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. Haematologica 2004;89(6_Suppl):ECR18-ECR18; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
